Grupo Petrotemex, S.A. DE C.V. v. Polymetrix AG

District Court, D. Minnesota·Decided July 23, 2020·No. 0:16-cv-02401·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

Grupo Petrotemex, S.A. DE C.V., Case No. 16-cv-2401 (SRN/HB) DAK Americas LLC,

Plaintiffs, ORDER

v.

Polymetrix AG,

Defendant.

Barbara D’Aquila and Margaret Rudolph, Norton Rose Fulbright US LLP, 60 S. 6th St., Ste. 3100, Minneapolis, MN 55402; Eric Schweibenz, J. Derek Mason, John F. Presper, and Alexander Englehart, Oblon, McClelland, Maier & Neustadt, LLP, 1940 Duke St., Alexandria, VA 22314, for Plaintiffs.

Bernard E. Nodzon, Jr., Theodore Budd, Timothy Sullivan, Faegre Drinker Biddle & Reath LLP, 90 S. 7th St., Ste. 2200, Minneapolis, MN 55402; Igor Shoiket, Stephen Youtsey, and Todd Noah, Dergosits & Noah LLP, One Embarcadero Center, Ste. 350, San Francisco, CA 94111, for Defendant

SUSAN RICHARD NELSON, United States District Judge This matter is before the Court on Plaintiffs’ Objections [Doc. No. 655] to Magistrate Judge Hildy Bowbeer’s July 20, 2020 Order (“the Order”) [Doc. No. 653]. In the Order, Magistrate Judge Bowbeer granted Defendant’s Motion to Compel, in which Defendant requested that the depositions of its employees and Rule 30(b)(6) corporate designees be conducted remotely. (Order at 2–10.) For the reasons set forth below, the Court overrules Plaintiffs’ Objections and affirms the Order. I. BACKGROUND

Plaintiffs Grupo Petrotemex, a Mexican corporation in the business of manufacturing polyethylene terephthalate (“PET”), a chemical used to make a variety of plastic products, and DAK Americas, a U.S. company that is the exclusive licensee of the patents in suit, brought this patent infringement lawsuit against Defendant Polymetrix, a Swiss corporation that designs, engineers, supplies, and builds plants that manufacture PET. (See Compl. [Doc. No. 1] ⁋⁋ 2–4, 17.) Plaintiffs allege that Polymetrix develops and sells polymer processing equipment that practices Plaintiffs’ patented inventions. (Id. ¶

15.) In the underlying motion, Polymetrix moved the Court for an order requiring that the previously noticed depositions of its employees and Rule 30(b)(6) designees, Messrs. Polyakov, Müller, and Christel, be taken the week of August 3, 2020, by remote video conference, with the witnesses physically located in Switzerland. (See Order at 1.)

Plaintiffs opposed the motion, arguing that the depositions should occur in-person, at a time and place mutually convenient to the parties, and in a manner consistent with the travel limitations necessitated by the COVID-19 pandemic. (Id.) In particular, Plaintiffs proposed to conduct the depositions in St. Maarten, a country in the Caribbean. (Id.) Magistrate Judge Bowbeer found, pursuant to Rule 30(b)(4), that the depositions

should be taken by remote means. (Id.) While the magistrate judge acknowledged that in- person depositions are desirable under ordinary circumstances, “these are not ordinary circumstances,” given the serious risks of COVID-19 posed by travel and in-person 2 gatherings at this time. (Id. at 2–3.) And although Plaintiffs’ proposed location of St. Maarten might be permissible from a legal or regulatory standpoint, Magistrate Judge

Bowbeer observed that holding depositions there could still require the parties and witnesses to self-quarantine upon returning home, and both travel and in-person proceedings could expose the participants to a substantially greater risk of contracting COVID-19 than if the depositions proceed remotely. (Id. at 3.) In addition, Magistrate Judge Bowbeer addressed the schedule and protocol for the depositions. (Id. at 4–10.) Due to the time-sensitive nature of the matters addressed in the

Order, the magistrate judge set a truncated period of time for a party to file an objection to the order, and for the opposing party to respond. Plaintiffs timely objected to the Order. They argue that the magistrate judge’s ruling “does not meaningfully address the specific facts of record here which demonstrate that any general concern over the risks posed by COVID-19 are lessened in this case for a

number of reasons.” (Pls.’ Objs. at 2.) They first note that none of Defendant’s witnesses have filed declarations identifying any specific health concerns that would prevent them from traveling to St. Maarten for in-person depositions. (Id.) Second, Plaintiffs assert that the magistrate judge failed to consider that St. Maarten has had less than 80 confirmed COVID-19 cases, only 15 deaths since March 2020, and, as of the Plaintiffs’ July 21, 2020

filing, only one confirmed case on the entire island. (Id.) Third, they contend that Switzerland currently has no requirement for self-isolation for travelers returning from St. Maarten. (Id.) Fourth, while Plaintiffs acknowledge that Rule 30(b)(4) does not require a 3 showing of good cause to permit remote depositions, they argue that the balance of interests requires Polymetrix to provide more than a “generalized fear of travel in light of the

COVID-19 pandemic.” (Id. at 2–3.) Finally, Plaintiffs assert that Defendant has slowed the progression of this case on failed jurisdictional challenges, such that it would be reasonable to “wait a while to see if the depositions could take place in person in London, Europe, or the U.S. in the not too distant future.” (Id. at 3.) In response, Defendant takes issue with several aspects of Plaintiffs’ proposal to conduct the depositions in St. Maarten, and urges the Court to affirm Magistrate Judge

Bowbeer’s Order. For instance, Defendant disputes Plaintiffs’ calculation of the estimated travel time for the witnesses, who would be flying from Zurich, Switzerland to St. Maarten, and the potential risk for defense counsel, who would be traveling from the San Francisco Bay Area through the COVID-19 hotspot of Miami. (Def.’s Resp. to Objs. [Doc. No. 659] at 2–3.) In addition, Defendant contends that it is entirely unclear whether St. Maarten will

even be accepting flights from the United States in early August, and whether counsel for both sides would meet St. Maarten’s entry requirements, which include testing within 72 hours prior to travel. (Id.) On a more fundamental level, Defendant asserts that it is unnecessary to provide statements or declarations expressing specific health concerns because the sole health concern of the defense witnesses and counsel is COVID-19, for

which the risks and hardships of in-person depositions are “obvious.” (Id. at 3, 7.)

4 II. DISCUSSION In reviewing an order from a magistrate judge on nondispositive matters, such as a

motion to compel, the standard of review “is extremely deferential.” Magee v. Trs. of the Hamline Univ., Minn., 957 F. Supp. 2d 1047, 1062 (D. Minn. 2013). The Court must set aside portions of an order only if they are “clearly erroneous or contrary to law.” 28 U.S.C. § 636(b)(1)(A); Fed. R. Civ. Proc. 72(a); Local Rule 72.2. Here, the magistrate judge’s Order was neither clearly erroneous nor contrary to law. Rule 30(b)(4) allows parties to stipulate, or the court to issue an order upon a motion,

that a deposition “be taken by telephone or other remote means.” Fed. R. Civ. P. 30(b)(4). COVID-19 “‘is a potentially fatal illness with the ability to spread through asymptomatic or pre-symptomatic carriers, with no approved cure, treatment, or vaccine[.]’” Rouviere v. DePuy Orthopaedics, Inc., No. 1:18-CV-04814 (LJL)(SDA), 2020 WL 3967665, at *3 (S.D.N.Y. July 11, 2020) (quoting Joffe v. King & Spalding LLP,

No. 17-CV-03392 (VEC), 2020 WL 3453452, at *7 (S.D.N.Y. June 24, 2020)) (footnote omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Grupo Petrotemex, S.A. DE C.V. v. Polymetrix AG, (mnd 2020).

Grupo Petrotemex, S.A. DE C.V. v. Polymetrix AG (Grupo Petrotemex, S.A. DE C.V. v. Polymetrix AG) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Magee v. Trustees of Hamline University
957 F. Supp. 2d 1047 (D. Minnesota, 2013)